Revolve Access is pleased to partner with Life Science Leader  on a recently published article, “ An Updated View of the Federal Segment...

Bottom Line: Integration of medical devices into VA telehealth appointments as core component of care creates a market opportunity for medical device manufacturers to become strategic partners in a national, unified healthcare system. The Department of Veterans Affairs’ (VA) dedication to innovative solutions in serving the unique needs of its veteran population is perhaps most evident in its approach to telehealth. Unlike commercial health systems that generally offer telehe

Bottom Line: The VA and DoD collaborate strategically on pharmaceutical management, leveraging their buying power, pooling resources in...

Bottom Line: The VA's Non-Formulary (NF) designation can be overcome through broad, compelling clinical justification demonstrating...

The Defense Health Agency’s Benefits Advisory Panel (BAP) has long served as a gatekeeper in the military health system’s formulary...

Bottom Line: By strategically collaborating with commercial Integrated Delivery Networks on pharmaceutical management, the VA is...

The VA and DoD are not “loss leader” channels. They are high-value, margin-stable, influence-rich markets where a single, well-executed...

Pharmaceutical manufacturers frequently misinterpret market opportunity within the distinct VA patient population by directly applying...

We know both VA and DoD partner with Kaiser - but how do these health systems actually compare? If you’re investing in Kaiser Permanente,...

Bottom Line: Understanding the mechanisms in which a community care provider can request extended or new medical treatments is core...

Bottomline: The VA Community Care program, while crucial for expanding veteran healthcare access, can result in reimbursement...

Bottom Line: The Department of Defense (DoD) is frequently the first federal payer to formally assess newly FDA-approved pharmaceutical...